täiskirje prindi

Development of safe and effective bacteriophage-mediated therapies against C. difficile infections – a proof-of-concept preclinical study

autor
vastutusandmed
Torben Sølbeck Rasmussen, Sarah Forster, Sabina Birgitte Larsen, Alexandra Von Münchow, Kaare Dyekær Tranæs, Anders Brunse, Josue Leonardo Castro Mejia, Signe Adamberg, Axel Kornerup Hansen, Kaarel Adamberg, Camilla Hartmann Friis Hansen, Dennis Sandris Nielsen
allikas
kirjastus/väljaandja
ilmumisaasta
leheküljed
28 p. : ill
leitav
ISSN
2692-8205
Open Access
Open Access (roheline)
keel
inglise
Rasmussen, T.S., Forster S., Larsen, S.B., Münchow A. von, Tranæs, K.D., Brunse, A.,Castro Mejia, J.L., Adamberg, S., Hansen, A.K., Adamberg, K. et al Development of safe and effective bacteriophage-mediated therapies against C. difficile infections – a proof-of-concept preclinical study // bioRxiv (2023), 28 p. : ill. https://doi.org/10.1101/2023.03.17.532897 https://www.biorxiv.org/content/biorxiv/early/2023/03/17/2023.03.17.532897.full.pdf